"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"
“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”
基本信息
- 批准号:10398467
- 负责人:
- 金额:$ 6.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-18 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAnimal ModelAntibodiesAutoimmuneAutoimmune encephalitisAwardBackBasic ScienceBrainClinicClinicalClinical TrialsDataDevelopment PlansDiseaseDoctor of PhilosophyEarly DiagnosisEarly treatmentEncephalitisEnvironmentFacultyFc ReceptorFellowshipFunctional disorderFundingGeneral HospitalsGoalsHerpes encephalitisHerpesvirus 1Hospital DepartmentsHumanImmune responseImmunologyK-Series Research Career ProgramsLaboratoriesLeadMagnetic ResonanceMassachusettsMentorsMethodologyModelingMolecular BiologyMolecular TargetMusN-Methyl-D-Aspartate ReceptorsNeurologistNeurologyPathogenesisPathogenicityPatient-Focused OutcomesPatientsPositron-Emission TomographyPublicationsPublishingResearchResearch PersonnelResearch ProposalsRodentRodent ModelScientistSolidTimeTrainingViralWorkcareer developmentdisabilityexperienceimprovedinstructormedical schoolsmembermolecular imagingmouse modelnervous system disordernoveltargeted biomarkertargeted imagingvirology
项目摘要
PROJECT SUMMARY / ABSTRACT:
The goals of this Mentored Clinical Scientist Research Career Development Award (K08) are to A) obtain
theoretical and hands-on training in 1) rodent magnetic resonance (MR) and positron emission tomography
(PET) molecular imaging and 2) virology and immunology, B) apply this training towards developing a rodent
model of viral-induced autoimmune encephalitis, and C) to use the resulting data to create a successful R01
application in the final years of this K08. This award will be a crucial stepping-stone towards my overall goal of
developing into an independent autoimmune neurologist that sees patients and studies these diseases in the
laboratory, contributing to earlier diagnoses and better treatments for these disabling disorders.
Autoimmune encephalitis can be fatal and can lead to significant disability. It is difficult to gather enough
patients with autoimmune encephalitis for clinical trials. There is a published rodent model of NMDA receptor
(NMDAR) encephalitis. However, it relies on the adoptive transfer of human anti-NMDAR antibodies into the
brains of mice. In order to study the pathogenesis of these disorders, it would be particularly important to
develop an animal model of NMDAR encephalitis which does not rely on exogenous antibodies. It has been
recently recognized in humans that some cases of NMDAR encephalitis are triggered by herpes simplex virus
(HSV) encephalitis. Rodent models of HSV encephalitis are established. Preliminary work by our lab showed
that some mice with HSV encephalitis make anti-NMDAR antibodies. This research proposal aims to
demonstrate the pathogenicity of these antibodies and to use this model to better understand the patho-
physiology of NMDAR encephalitis. This will be done by using targeted molecular imaging to understand the
mechanisms as well as profiling the immune responses involved in this autoimmune neurologic disorder.
I am a board-certified Harvard-trained neurologist with specific clinical fellowship training in autoimmune
neurology through the Mayo Clinic. I have obtained the top clinical training available in this field. Furthermore,
I have gained additional experience in basic research within this topic by spending time in the laboratory of the
renowned autoimmune neurologist Dr. Josep Dalmau, one of my co-mentors on this project. I bring a solid
grounding in molecular biology, gained through my Ph.D. studies. In addition, I have a strong publication and
funding record. The research career development plan outlined within this proposal will equip me with a better
understanding of virology and immunology and the latest methodologies within these fields that can be applied
to uncover the pathophysiology of parainfectious autoimmune neurologic disorders. The research environment
across the MGH, Harvard, and MIT campuses is outstanding and my mentors have the relevant and necessary
expertise to guide this career development plan. I am a full time faculty member in the Massachusetts General
Hospital (MGH) Department of Neurology and an Instructor in Neurology at Harvard Medical School. I have
the full backing of the chair of my department, Dr. Cudkowicz, to develop into an independent researcher.
项目摘要/摘要:
指导临床科学家研究职业发展奖 (K08) 的目标是 A) 获得
1) 啮齿动物磁共振(MR)和正电子发射断层扫描的理论和实践培训
(PET) 分子成像和 2) 病毒学和免疫学,B) 将这种培训应用于开发啮齿动物
病毒诱发的自身免疫性脑炎模型,以及 C) 使用所得数据创建成功的 R01
在 K08 的最后几年申请。这个奖项将成为我实现总体目标的重要垫脚石
发展成为一名独立的自身免疫神经科医生,在现场观察患者并研究这些疾病
实验室,有助于这些致残性疾病的早期诊断和更好的治疗。
自身免疫性脑炎可能致命,并可能导致严重残疾。很难收集到足够的
自身免疫性脑炎患者进行临床试验。有已发表的 NMDA 受体啮齿动物模型
(NMDAR) 脑炎。然而,它依赖于将人类抗 NMDAR 抗体过继转移到体内
老鼠的大脑。为了研究这些疾病的发病机制,特别重要的是
开发不依赖外源抗体的 NMDAR 脑炎动物模型。它一直
最近在人类中发现一些 NMDAR 脑炎病例是由单纯疱疹病毒引发的
(单纯疱疹病毒)脑炎。建立HSV脑炎啮齿动物模型。我们实验室的初步工作表明
一些患有 HSV 脑炎的小鼠会产生抗 NMDAR 抗体。本研究计划旨在
证明这些抗体的致病性并使用该模型更好地了解致病性
NMDAR 脑炎的生理学。这将通过使用靶向分子成像来了解
机制以及分析与这种自身免疫性神经系统疾病有关的免疫反应。
我是一名经过董事会认证、经过哈佛大学培训的神经科医生,接受过自身免疫方面的特定临床研究员培训
梅奥诊所的神经病学。我已经获得了该领域的顶级临床培训。此外,
通过在实验室的工作,我获得了该主题基础研究的额外经验
著名的自身免疫神经学家 Josep Dalmau 博士是我在这个项目上的合作导师之一。我带来了固体
通过我的博士学位获得了分子生物学的基础。研究。此外,我还有强大的出版物和
资金记录。本提案中概述的研究职业发展计划将使我拥有更好的能力
了解病毒学和免疫学以及这些领域内可以应用的最新方法
揭示副感染性自身免疫性神经系统疾病的病理生理学。研究环境
在麻省总医院、哈佛大学和麻省理工学院校园中的表现都很出色,我的导师拥有相关且必要的知识
指导该职业发展计划的专业知识。我是马萨诸塞州综合医院的全职教员
医院 (MGH) 神经内科和哈佛医学院神经内科讲师。我有
在我系主任 Cudkowicz 博士的全力支持下,我成长为一名独立研究员。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.
美国首发精神病患者自身免疫性脑炎常规筛查的成本效益。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Ross, Eric L;Becker, Jessica E;Linnoila, Jenny J;Soeteman, Djøra I
- 通讯作者:Soeteman, Djøra I
Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis.
与副肿瘤性抗 N-甲基-D-天冬氨酸受体脑炎相关的区域转移性默克尔细胞癌。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Shalhout, Sophia Z;Emerick, Kevin S;Sadow, Peter M;Linnoila, Jenny J;Miller, David M
- 通讯作者:Miller, David M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNY J LINNOILA其他文献
JENNY J LINNOILA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNY J LINNOILA', 18)}}的其他基金
"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"
“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”
- 批准号:
9295591 - 财政年份:2017
- 资助金额:
$ 6.67万 - 项目类别:
"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"
“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”
- 批准号:
10066374 - 财政年份:2017
- 资助金额:
$ 6.67万 - 项目类别:
Signaling Mechanisms Behind nAChR Clustering at the NMJ
NMJ nAChR 聚类背后的信号机制
- 批准号:
7482284 - 财政年份:2007
- 资助金额:
$ 6.67万 - 项目类别:
Signaling Mechanisms Behind nAChR Clustering at the NMJ
NMJ nAChR 聚类背后的信号机制
- 批准号:
7331196 - 财政年份:2007
- 资助金额:
$ 6.67万 - 项目类别:
相似国自然基金
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
中东呼吸综合征新型人源应急救治单克隆抗体保护作用机制研究
- 批准号:81772191
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
IL-17促进系统性红斑狼疮发病中浆细胞功能的机制研究
- 批准号:81771761
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
肺腺癌中Timp-1促癌机制的研究及其阻断抗体的运用
- 批准号:81672268
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
抗磷脂抗体诱导中性粒细胞释放NETs致抗磷脂综合征肾病的机制研究
- 批准号:81671589
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 6.67万 - 项目类别:
POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION
溶瘤病毒原位疫苗接种增强抗肿瘤免疫力
- 批准号:
10908106 - 财政年份:2023
- 资助金额:
$ 6.67万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 6.67万 - 项目类别:
Combining Radiation, Allogeneic Natural Killer Immunotherapy, and PD-L1 blockade in Dogs with Naturally-Occurring Melanoma
结合放疗、同种异体自然杀伤免疫疗法和 PD-L1 阻断治疗患有天然黑色素瘤的狗
- 批准号:
10679952 - 财政年份:2023
- 资助金额:
$ 6.67万 - 项目类别: